{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:56:53Z","timestamp":1781647013589,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006196","name":"University of Oulu","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Local and systemic inflammation play key roles in colorectal cancer (CRC). Matrix metalloproteinase 8 (MMP8), an enzyme involved in extracellular matrix remodeling, has been linked to both inflammatory processes and cancer progression. This study investigates MMP8 serum concentration and MMP8 expression within the tumor microenvironment, and their relationship with tumor characteristics, inflammation, and survival. The study included 776 stage I-IV CRC patients. MMP8\n                    <jats:sup>+<\/jats:sup>\n                    cell densities within tumors were analyzed using immunohistochemistry combined with digital image analysis, while preoperative serum MMP8 levels were analyzed using an immunofluorometric assay. Survival analyses were performed using the Kaplan-Meier method and Cox regression models. Correlations with systemic inflammatory markers and immune cell densities were assessed using linear regression models. We found that MMP8 was predominantly expressed by CEACAM8\n                    <jats:sup>+<\/jats:sup>\n                    granulocytes. High MMP8\n                    <jats:sup>+<\/jats:sup>\n                    cell density within tumors was associated with favorable prognostic factors, including low disease stage, absent lymphovascular invasion, and mismatch repair (MMR) deficiency, but also with improved cancer-specific survival independent of these factors. The multivariable HR for low (vs. high) MMP8\n                    <jats:sup>+<\/jats:sup>\n                    cell density was 1.76 (95%CI 1.18\u20132.60). MMP8\n                    <jats:sup>+<\/jats:sup>\n                    cell density positively correlated with T-cell densities, but not with serum MMP8 levels or conventional systemic inflammation markers. In contrast, high serum MMP8 levels were associated with systemic inflammation and worse survival, but did not remain an independent prognostic factor in multivariable models. In conclusion, serum MMP8 levels do not correlate with MMP8 expression in the tumor microenvironment, suggesting distinct roles for circulating and tumor-associated MMP8 in CRC progression. High MMP8\n                    <jats:sup>+<\/jats:sup>\n                    cell densities within tumors are associated with better prognosis and local immune activity, while elevated serum MMP8 levels indicate systemic inflammation and advanced disease.\n                  <\/jats:p>","DOI":"10.1007\/s10238-026-02131-5","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:25:29Z","timestamp":1775193929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opposing prognostic roles of tumor-associated and circulating MMP8 in colorectal cancer"],"prefix":"10.1007","volume":"26","author":[{"given":"Iivari","family":"Loukasm\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tuomisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Sirni\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeri","family":"Kastinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"Karjalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville K.","family":"\u00c4ij\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilja V.","family":"Tapiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taina","family":"Tervahartiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Sorsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa-Matti","family":"Pohjanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taneli T.","family":"Mattila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Rintala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Meril\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Saarnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Rautio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-2996","authenticated-orcid":false,"given":"Juha P.","family":"V\u00e4yrynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"2131_CR1","first-page":"1145","volume":"132","author":"J-P Mecklin","year":"2016","unstructured":"Mecklin J-P, Malila N, K\u00e4\u00e4ri\u00e4inen H, Pajari AM, F\u00e4rkkil\u00e4 M. Suolistosy\u00f6v\u00e4n riskitekij\u00e4t ja ehk\u00e4isyn mahdollisuudet. Duodecim. 2016;132:1145\u201352.","journal-title":"Duodecim"},{"key":"2131_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/CAAC.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/CAAC.21834.","journal-title":"CA Cancer J Clin"},{"key":"2131_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/J.TRANON.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14:101174. https:\/\/doi.org\/10.1016\/J.TRANON.2021.101174.","journal-title":"Transl Oncol"},{"key":"2131_CR4","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/bjc.2013.508","volume":"109","author":"JP V\u00e4yrynen","year":"2013","unstructured":"V\u00e4yrynen JP, Tuomisto A, Klintrup K, M\u00e4kel\u00e4 J, Karttunen TJ, M\u00e4kinen MJ. Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer. 2013;109:1839\u201347. https:\/\/doi.org\/10.1038\/bjc.2013.508.","journal-title":"Br J Cancer"},{"key":"2131_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/J.CTRV.2011.09.001","volume":"38","author":"CSD Roxburgh","year":"2012","unstructured":"Roxburgh CSD, McMillan DC. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev. 2012;38:451\u201366. https:\/\/doi.org\/10.1016\/J.CTRV.2011.09.001.","journal-title":"Cancer Treat Rev"},{"key":"2131_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.1039260","author":"C Lu","year":"2023","unstructured":"Lu C, Liu Y, Ali NM, Zhang B, Cui X. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/FIMMU.2022.1039260.","journal-title":"Front Immunol"},{"key":"2131_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/NCB3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717. https:\/\/doi.org\/10.1038\/NCB3015.","journal-title":"Nat Cell Biol"},{"key":"2131_CR8","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.3748\/WJG.V25.I31.4383","volume":"25","author":"AE Tuomisto","year":"2019","unstructured":"Tuomisto AE, M\u00e4kinen MJ, V\u00e4yrynen JP. Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019;25:4383. https:\/\/doi.org\/10.3748\/WJG.V25.I31.4383.","journal-title":"World J Gastroenterol"},{"key":"2131_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/J.CARDIORES.2005.12.002\/2\/69-3-562-FIG3.GIF","volume":"69","author":"H Nagase","year":"2006","unstructured":"Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562\u201373. https:\/\/doi.org\/10.1016\/J.CARDIORES.2005.12.002\/2\/69-3-562-FIG3.GIF.","journal-title":"Cardiovasc Res"},{"key":"2131_CR10","unstructured":"MMP8 matrix metallopeptidase 8 [Homo sapiens (human)] - Gene - NCBI [Internet]. Accessed 16. Jan 2026. https:\/\/www.ncbi.nlm.nih.gov\/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=4317"},{"key":"2131_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/J.CYTOGFR.2006.04.001","volume":"17","author":"P Van Lint","year":"2006","unstructured":"Van Lint P, Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 2006;17:217\u201323. https:\/\/doi.org\/10.1016\/J.CYTOGFR.2006.04.001.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2131_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/ECI.12649","volume":"46","author":"A Lauhio","year":"2016","unstructured":"Lauhio A, F\u00e4rkkil\u00e4 E, Pietil\u00e4inen KH, \u00c5str\u00f6m P, Winkelmann A, Tervahartiala T, et al. Association of MMP-8 with obesity, smoking and insulin resistance. Eur J Clin Invest. 2016;46:757\u201365. https:\/\/doi.org\/10.1111\/ECI.12649.","journal-title":"Eur J Clin Invest"},{"key":"2131_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/S41416-018-0136-4","volume":"119","author":"P Sirni\u00f6","year":"2018","unstructured":"Sirni\u00f6 P, Tuomisto A, Tervahartiala T, Sorsa T, Klintrup K, Karhu T, et al. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer. Br J Cancer. 2018;119:213. https:\/\/doi.org\/10.1038\/S41416-018-0136-4.","journal-title":"Br J Cancer"},{"key":"2131_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS20184506","author":"K Juurikka","year":"2019","unstructured":"Juurikka K, Butler GS, Salo T, Nyberg P, \u00c5str\u00f6m P. The role of MMP8 in cancer: a systematic review. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/IJMS20184506.","journal-title":"Int J Mol Sci"},{"key":"2131_CR15","doi-asserted-by":"publisher","unstructured":"V\u00e4yrynen JP, Vornanen J, Tervahartiala T, Sorsa T, Bloigu R, Salo T, et al. Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors. Int J Cancer. 2012;131. https:\/\/doi.org\/10.1002\/IJC.26435.","DOI":"10.1002\/IJC.26435"},{"key":"2131_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/PAS.0000000000002286","volume":"48","author":"M Kastinen","year":"2024","unstructured":"Kastinen M, Sirni\u00f6 P, Elomaa H, \u00c4ij\u00e4l\u00e4 VK, Karjalainen H, Tapiainen VV, et al. Establishing criteria for tumor necrosis as prognostic indicator in colorectal cancer. Am J Surg Pathol. 2024;48:1284\u201392. https:\/\/doi.org\/10.1097\/PAS.0000000000002286.","journal-title":"Am J Surg Pathol"},{"key":"2131_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/JAMA.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669\u201385. https:\/\/doi.org\/10.1001\/JAMA.2021.0106.","journal-title":"JAMA"},{"key":"2131_CR18","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/JNCI\/DJI237","volume":"97","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst. 2005;97:1180\u20134. https:\/\/doi.org\/10.1093\/JNCI\/DJI237.","journal-title":"J Natl Cancer Inst"},{"key":"2131_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/S12967-019-1950-Z","volume":"17","author":"JP V\u00e4yrynen","year":"2019","unstructured":"V\u00e4yrynen JP, V\u00e4yrynen SA, Sirni\u00f6 P, Minkkinen I, Klintrup K, Karhu T, et al. Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer. J Transl Med. 2019;17:199. https:\/\/doi.org\/10.1186\/S12967-019-1950-Z.","journal-title":"J Transl Med"},{"key":"2131_CR20","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/S41416-023-02258-2","volume":"128","author":"M Kastinen","year":"2023","unstructured":"Kastinen M, Sirni\u00f6 P, Elomaa H, Ahtiainen M, V\u00e4yrynen SA, Herzig KH, et al. Immunological and prognostic significance of tumour necrosis in colorectal cancer. Br J Cancer. 2023;128:2218\u201326. https:\/\/doi.org\/10.1038\/S41416-023-02258-2.","journal-title":"Br J Cancer"},{"key":"2131_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-017-17204-5","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/S41598-017-17204-5.","journal-title":"Sci Rep"},{"key":"2131_CR22","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1158\/1078-0432.CCR-20-0071","volume":"26","author":"JP V\u00e4yrynen","year":"2020","unstructured":"V\u00e4yrynen JP, Lau MC, Haruki K, V\u00e4yrynen SA, Dias Costa A, Borowsky J, et al. Prognostic significance of immune cell populations identified by machine learning in colorectal cancer using routine hematoxylin and eosin-stained sections. Clin Cancer Res. 2020;26:4326\u201338. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0071.","journal-title":"Clin Cancer Res"},{"key":"2131_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/S41416-022-01822-6","volume":"127","author":"H Elomaa","year":"2022","unstructured":"Elomaa H, Ahtiainen M, V\u00e4yrynen SA, Ogino S, Nowak JA, Friman M, et al. Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer. Br J Cancer. 2022;127:514\u201323. https:\/\/doi.org\/10.1038\/S41416-022-01822-6.","journal-title":"Br J Cancer"},{"key":"2131_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/JCP.2006.044537","volume":"60","author":"I Zlobec","year":"2007","unstructured":"Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol. 2007;60:1112\u20136. https:\/\/doi.org\/10.1136\/JCP.2006.044537.","journal-title":"J Clin Pathol"},{"key":"2131_CR25","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.918133","volume":"25","author":"JW Zhong","year":"2019","unstructured":"Zhong JW, Yang SX, Chen RP, Zhou YH, Ye MS, Miao L, et al. Prognostic value of lymphovascular invasion in patients with stage III colorectal cancer: a retrospective study. Med Sci Monit. 2019;25:6043. https:\/\/doi.org\/10.12659\/MSM.918133.","journal-title":"Med Sci Monit"},{"key":"2131_CR26","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1158\/1078-0432.CCR-07-1489","volume":"14","author":"AJ French","year":"2008","unstructured":"French AJ, Sargent DJ, Burgart LJ, Foster NR, Kabat BF, Goldberg R, et al. Prognostic significance of defective mismatch repair and BRAF-V600E in patients with colon cancer. Clin Cancer Res. 2008;14:3408. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1489.","journal-title":"Clin Cancer Res"},{"key":"2131_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/ONCOLO\/OYAB055","volume":"27","author":"E Tan","year":"2022","unstructured":"Tan E, Whiting J, Xie H, Imanirad I, Carballido E, Felder S, et al. BRAF mutations are associated with poor survival outcomes in advanced-stage mismatch repair-deficient\/microsatellite high colorectal cancer. Oncologist. 2022;27:191. https:\/\/doi.org\/10.1093\/ONCOLO\/OYAB055.","journal-title":"Oncologist"},{"key":"2131_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/J.TRECAN.2023.09.011","volume":"10","author":"A Aiderus","year":"2024","unstructured":"Aiderus A, Barker N, Tergaonkar V. Serrated colorectal cancer: preclinical models and molecular pathways. Trends Cancer. 2024;10:76\u201391. https:\/\/doi.org\/10.1016\/J.TRECAN.2023.09.011.","journal-title":"Trends Cancer"},{"key":"2131_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/sj.bjc.6604239","volume":"98","author":"JT Korpi","year":"2008","unstructured":"Korpi JT, Kervinen V, M\u00e4klin H, V\u00e4\u00e4n\u00e4nen A, Lahtinen M, L\u00e4\u00e4ra E, et al. Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer. Br J Cancer. 2008;98:766\u201375. https:\/\/doi.org\/10.1038\/sj.bjc.6604239.","journal-title":"Br J Cancer"},{"key":"2131_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/S12943-024-02004-Z","author":"X Huang","year":"2024","unstructured":"Huang X, Nepovimova E, Adam V, Sivak L, Heger Z, Valko M, et al. Neutrophils in cancer immunotherapy: friends or foes? Mol Cancer. 2024. https:\/\/doi.org\/10.1186\/S12943-024-02004-Z.","journal-title":"Mol Cancer"},{"key":"2131_CR31","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S185350","volume":"11","author":"X Lu","year":"2018","unstructured":"Lu X, Guo W, Xu W, Zhang X, Shi Z, Zheng L, et al. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients. Cancer Manag Res. 2018;11:229. https:\/\/doi.org\/10.2147\/CMAR.S185350.","journal-title":"Cancer Manag Res"},{"key":"2131_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/FON.09.136","volume":"6","author":"CSD Roxburgh","year":"2010","unstructured":"Roxburgh CSD, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149\u201363. https:\/\/doi.org\/10.2217\/FON.09.136.","journal-title":"Future Oncol"},{"key":"2131_CR33","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0967-12.2012","volume":"32","author":"RE Vandenbroucke","year":"2012","unstructured":"Vandenbroucke RE, Dejonckheere E, Van Lint P, Demeestere D, Van Wonterghem E, Vanlaere I, et al. Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood\u2013CSF barrier contributes to lethality during systemic inflammatory diseases. J Neurosci. 2012;32:9805. https:\/\/doi.org\/10.1523\/JNEUROSCI.0967-12.2012.","journal-title":"J Neurosci"},{"key":"2131_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/bjc.2013.291","volume":"109","author":"GJK Guthrie","year":"2013","unstructured":"Guthrie GJK, Roxburgh CSD, Richards CH, Horgan PG, McMillan DC. Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer. Br J Cancer. 2013;109:131\u20137. https:\/\/doi.org\/10.1038\/bjc.2013.291.","journal-title":"Br J Cancer"},{"key":"2131_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1783046","volume":"9","author":"P Sirni\u00f6","year":"2020","unstructured":"Sirni\u00f6 P, V\u00e4yrynen JP, Mutt SJ, Herzig KH, Walkowiak J, Klintrup K, et al. Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancer. Oncoimmunology. 2020;9:1783046. https:\/\/doi.org\/10.1080\/2162402X.2020.1783046.","journal-title":"Oncoimmunology"},{"key":"2131_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/J.SEMCDB.2007.06.006","volume":"19","author":"B Fingleton","year":"2008","unstructured":"Fingleton B. MMPs as therapeutic targets\u2013still a viable option? Semin Cell Dev Biol. 2008;19:61\u20138. https:\/\/doi.org\/10.1016\/J.SEMCDB.2007.06.006.","journal-title":"Semin Cell Dev Biol"},{"key":"2131_CR37","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/J.1582-4934.2011.01302.X","volume":"15","author":"J Decock","year":"2011","unstructured":"Decock J, Thirkettle S, Wagstaff L, Edwards DR. Matrix metalloproteinases: protective roles in cancer. J Cell Mol Med. 2011;15:1254\u201365. https:\/\/doi.org\/10.1111\/J.1582-4934.2011.01302.X.","journal-title":"J Cell Mol Med"},{"key":"2131_CR38","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.1158\/0008-5472.CAN-07-1683","volume":"67","author":"J Decock","year":"2007","unstructured":"Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, et al. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res. 2007;67:10214\u201321. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1683.","journal-title":"Cancer Res"},{"key":"2131_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/NATURE07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344. https:\/\/doi.org\/10.1038\/NATURE07205.","journal-title":"Nature"},{"key":"2131_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/J.1742-4658.2010.07919.X","volume":"278","author":"C Gialeli","year":"2011","unstructured":"Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targetingFEBS J. FEBS J. 2011;278:16\u201327. https:\/\/doi.org\/10.1111\/J.1742-4658.2010.07919.X.","journal-title":"FEBS J"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02131-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02131-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02131-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:26:01Z","timestamp":1781645161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02131-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2131"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02131-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted under approval from the Regional medical research ethics committee of the Wellbeing services county of North Ostrobothnia (25\/2002, 42\/2005, 122\/2009, 37\/2020), Biobank Borealis (BB-2017_1012) and Fimea (FIMEA\/2022\/001941). The study was adhered to the ethical guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}],"article-number":"225"}}